Increased
3.66% → 4.19%
ARK Invest added 791,566 shares; portfolio weight moved from 3.66% to 4.19%.
+791,566 Shares
+7.52%
Back to 13F data
Healthcare
CRISPR Therapeutics AG
CRISPR Therapeutics AG is tracked here as a normalized 13F company record; no curated business description is available yet.
Original CUSIPs: H17182108. This page shows current managers, quarterly changes, and primary SEC sources.
Current managers
1
Latest reporting quarter
Q1 2026
Who holds it and what changed this quarter
Portfolio weight and share-count changes are shown for every tracked manager with a current or prior-quarter position.
SEC05/12/2026
Four-quarter trend
Each line is one tracked manager’s portfolio weight. Labels identify the manager directly.
Historical and source details
Market values, quarterly totals, and original CUSIP rows are available below without obscuring current actions.
Quarterly holdings details
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $495,281,183 | 10,182,590 | ARK Invest New position · 10,182,590 Shares |
| Q3 2025 | 1 | $634,293,721 | 9,786,973 | ARK Invest Reduced · 9,786,973 Shares |
| Q4 2025 | 1 | $551,776,677 | 10,522,057 | ARK Invest Increased · 10,522,057 Shares |
| Q1 2026 | 1 | $538,189,027 | 11,313,623 | ARK Invest Increased · 11,313,623 Shares |
Original CUSIP details
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| ARK Invest | CRISPR Therapeutics AG | H17182108 | Common Stock | $538,189,027 | 11,313,623 | 4.19% | SEC XML |
Data source
Holdings facts come from SEC 13F information tables. Tickers, company aliases, and themes are used only for search and normalized display, not as a holdings source.